Silk Road Medical: Unsure On Economics Given List Of Probabilities (NASDAQ:SILK)

Business on Wall Street in Manhattan

Pgiam/iStock via Getty Images

Investment briefing

Silk Road Medical, Inc. (NASDAQ:SILK) posted Q2 FY’23 numbers last week with a reasonable performance throughout the P&L and cash flow statement and balance sheet strength. Despite this, the outlook is mixed on the

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *